Betamethasone in hernia surgery: a randomized controlled trial

Area of Science:

• Anesthesiology
• Surgical Oncology
• Pharmacology

Background:

• Post-operative pain and nausea are common complications in day-case surgery.
• Inguinal hernia surgery often involves significant post-operative discomfort.
• Effective pain management strategies are crucial for patient recovery and satisfaction.

Purpose of the Study:

• To evaluate the efficacy of betamethasone in managing pain and nausea after open inguinal hernia surgery.
• To compare the outcomes of betamethasone treatment versus placebo in this patient population.
• To assess the impact of betamethasone on pain at various post-operative time points.

Main Methods:

• A randomized controlled trial involving 398 patients undergoing open inguinal hernia surgery.
• Patients received either 12mg of intravenous betamethasone or a placebo.
• Pain was assessed using a visual analogue scale and the Inguinal Pain Questionnaire at multiple intervals up to one year post-surgery.

Main Results:

• Betamethasone significantly reduced pain at rest on the day of surgery and 24 hours post-surgery.
• A significant reduction in pain was observed one month post-surgery in the betamethasone group.
• An increased risk of bleeding complications was noted in the betamethasone group (p=0.028).

Conclusions:

• A 12mg dose of betamethasone effectively reduces pain in the early post-operative period and at one month after inguinal hernia surgery.
• The combination of betamethasone with diclofenac may elevate the risk of bleeding complications.
• Further research is warranted to optimize the use of betamethasone in surgical pain management.